| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.006 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0018 | 1 |